Collateral Effects and Mortality of Kidney Transplant Recipients during the COVID-19 Pandemic.

Despite significant collateral effects, mortality remained unchanged during the early COVID-19 pandemic. Considerable temporary reductions in admissions are safe, whereas reducing immunosuppression results in increased allograft rejection risk.